Bajetta E - Search Results

1

Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer.

Bajetta E, Verzoni E, Ferrario E, Dotti K, Gevorgyan A, Celio L. Bajetta E, et al. Tumori. 2009 Jan-Feb;95(1):43-7. doi: 10.1177/030089160909500108. Tumori. 2009. PMID: 19366055 Clinical Trial.

2

Formestane as treatment of advanced breast cancer in elderly women.

Zilembo N, Buzzoni R, Celio L, Noberasco C, Ferrari L, Laffranchi A, Vicario G, Dolci S, Bajetta E. Zilembo N, et al. Among authors: bajetta e. Tumori. 1994 Dec 31;80(6):433-7. doi: 10.1177/030089169408000605. Tumori. 1994. PMID: 7900232 Clinical Trial.

3

Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.

Bajetta E, Rimassa L, Carnaghi C, Del Vecchio M, Celio L, Cassata A. Bajetta E, et al. Tumori. 1998 Jan-Feb;84(1):48-51. doi: 10.1177/030089169808400110. Tumori. 1998. PMID: 9619714 Clinical Trial.

4

Fluoropyrimidines in the treatment of advanced neoplastic diseases: role and advantages of UFT.

Del Vecchio M, Procopio G, Cassata A, Pozzi P, Busto G, Celio L, Bajetta E. Del Vecchio M, et al. Among authors: bajetta e. Tumori. 1999 Jan-Feb;85(1):6-11. doi: 10.1177/030089169908500102. Tumori. 1999. PMID: 10228489 Review.

5

Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.

Cassata A, Procoplo G, Alù M, Ferrari L, Ferrario E, Beretta E, Longarini R, Busto G, De Candis D, Bajetta E. Cassata A, et al. Among authors: bajetta e. Tumori. 2001 Nov-Dec;87(6):364-71. doi: 10.1177/030089160108700602. Tumori. 2001. PMID: 11989587 Review.

6

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

Bajetta E, Celio L, Ferrario E, Di Bartolomeo M, Denaro A, Dotti K, Mancin M, Bajetta R, Colombo A, Pusceddu S. Bajetta E, et al. Among authors: bajetta r. Ann Oncol. 2007 Nov;18(11):1810-6. doi: 10.1093/annonc/mdm347. Epub 2007 Sep 6. Ann Oncol. 2007. PMID: 17823385 Free article. Clinical Trial.

7

Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients.

Bajetta E, Beretta E, Di Bartolomeo M, Cortinovis D, Ferrario E, Dognini G, Toffolatti L, Buzzoni R. Bajetta E, et al. Oncology. 2004;66(2):132-7. doi: 10.1159/000077439. Oncology. 2004. PMID: 15138365 Clinical Trial.

8

Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer.

Cortinovis D, Bajetta E, Di Bartolomeo M, Dognini G, Beretta E, Ferrario E, Ricotta R, Buzzoni R. Cortinovis D, et al. Among authors: bajetta e. Tumori. 2004 Mar-Apr;90(2):186-91. doi: 10.1177/030089160409000205. Tumori. 2004. PMID: 15237580 Clinical Trial.

9

Irinotecan, fluorouracil and folinic acid (FOLFIRI) as effective treatment combination for patients with advanced gastric cancer in poor clinical condition.

Beretta E, Di Bartolomeo M, Buzzoni R, Ferrario E, Mariani L, Gevorgyan A, Bajetta E. Beretta E, et al. Among authors: bajetta e. Tumori. 2006 Sep-Oct;92(5):379-83. doi: 10.1177/030089160609200502. Tumori. 2006. PMID: 17168428 Clinical Trial.

10

Renal cell cancer and sorafenib: skin toxicity and treatment outcome.

Bajetta E, Procopio G, Verzoni E, Catena L, De Dosso S, Platania M, Gevorgyan A. Bajetta E, et al. Tumori. 2007 Mar-Apr;93(2):201-3. doi: 10.1177/030089160709300216. Tumori. 2007. PMID: 17557570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters